Bristol-Myers Squibb
BMY
$65.16
Share price
-0.49%
Change (1 day)
-14.92%
Change (1 year)
Categories
Bristol-Myers Squibb (BMY) - Total debt
Total debt on the balance sheet as of March 2023 : $39.37 B
According to Bristol-Myers Squibb's latest financial reports the company's total debt is $39.37 B. A company’s total debt is the sum of all current and non-current debts.
Bristol-Myers Squibb - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $40.71 B | -10.7% |
| 2021-12-31 | $45.59 B | -11.76% |
| 2020-12-31 | $51.67 B | 8.7% |
| 2019-12-31 | $47.53 B | 546.86% |
| 2018-12-31 | $7.34 B | -7.7% |
| 2017-12-31 | $7.96 B | 18.69% |
| 2016-12-31 | $6.70 B | 0.28% |
| 2015-12-31 | $6.68 B | -14.59% |
| 2014-12-31 | $7.83 B | -6.09% |
| 2013-12-31 | $8.34 B | 12.79% |
| 2012-12-31 | $7.39 B | 34.66% |
| 2011-12-31 | $5.49 B | 0.84% |
| 2010-12-31 | $5.44 B | -14.4% |
| 2009-12-31 | $6.36 B | -5.61% |
| 2008-12-31 | $6.73 B | 7.45% |
| 2007-12-31 | $6.27 B | -15.64% |
| 2006-12-31 | $7.43 B | -13.5% |
| 2005-12-31 | $8.59 B | -16.92% |
| 2004-12-31 | $10.34 B | 19.62% |
| 2003-12-31 | $8.64 B | 13.21% |
| 2002-12-31 | $7.64 B | 19.17% |
| 2001-12-31 | $6.41 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $39.65 B | 0.73% | 🇺🇸 USA |
 Novartis NVS | $29.20 B | -25.82% | 🇨🇭 Switzerland |
 Pfizer PFE | $34.87 B | -11.43% | 🇺🇸 USA |
 AbbVie ABBV | $63.27 B | 60.70% | 🇺🇸 USA |
 Eli Lilly LLY | $18.88 B | -52.04% | 🇺🇸 USA |
 Amgen AMGN | $61.59 B | 56.45% | 🇺🇸 USA |
 Sanofi SNY | $22.71 B | -42.30% | 🇫🇷 France |
 Biogen BIIB | $6.60 B | -83.21% | 🇺🇸 USA |
 Merck MRK | $30.69 B | -22.05% | 🇺🇸 USA |
 AstraZeneca AZN | $31.50 B | -19.98% | 🇬🇧 UK |